Forty-seven genes were linked to patient survival.
Oncology
Advertisement
Lower education level was linked to reduced access to mutational testing and clinical trials.
The prospective case series demonstrates the efficacy of the combination in second- and later-line treatment.
Targeted therapies directed toward tumor genotype should be considered in addition to standard-of-care regimens.
New biomarker 2,3,6-trichlorobenzaldehyde shows 95% accuracy in blood tests for early cervical cancer and CIN detection.
Menstrual blood HPV testing shows 100% match with cervical smears—non-invasive, accurate, and preferred by most women.
This was an unexpected finding because mature TLS are typically rare in poorly immunogenic HPV-negative HNSCC.
Tumor mutations were even detected in early-stage disease.
The findings reaffirm concurrent chemoradiotherapy as a cornerstone of treatment.
Patient-derived cells have the potential to enhance drug screening tools and improve patient outcomes.
Researchers identified the pathologic and clinical characteristics of patients who experience disease relapse.
Advertisement
Expert Interviews on Oncology
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.